Production of a DPP Activity Gradient in the Early Drosophila Embryo through the Opposing Actions of the SOG and TLD Proteins  by Marqués, Guillermo et al.
Cell, Vol. 91, 417±426, October 31, 1997, Copyright 1997 by Cell Press
Production of a DPP Activity Gradient in the
Early Drosophila Embryo through the
Opposing Actions of the SOG and TLD Proteins
ectopic bone formation in rats (Wozney et al., 1988).
More recently, however, numerous knockout and classi-
cal mouse mutations have shown that these factors not
only influence skeletal growth and patterning, but also
control limb,somite, neural patterning, toothmorphogene-
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sis, spermatogenesis, and organogenesis (reviewed in²Developmental and Cell Biology
Hogan, 1996). In Xenopus, BMP-4 is expressed in the³The Developmental Biology Center
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as a diffusible morphogen in Xenopus toelicit differential
gene expression and cell fate depending on its concen-
tration (Green et al., 1992; Gurdon et al., 1995). HowSummary
direct these effects are has been called into question,
and it is possible that some of these concentration-During early Drosophila embryogenesis, several zy-
dependent effects could come about by a relay mecha-gotic gene products act to establish a posttranscrip-
nism (Reilly and Melton, 1996).tional activity gradient of the morphogen DPP. Among
In Drosophila, decapentaplegic (dpp), a functionalthese molecules, Tolloid, a putative metalloprotease
ortholog of BMP-2/4, controls several aspects of Dro-related to BMP-1, enhances DPP function, while SOG,
sophila development including early dorsal-ventral pat-an ortholog of the Xenopus organizer Chordin, inhibits
terning, induction of the dorsal mesoderm, gut morpho-DPP function. Using epistasis tests and a Xenopus
genesis, and outgrowth and patterning of imaginal diskssecondary axis induction assay, we show that TLD
(reviewed in Gelbart, 1989; Hoffmann, 1991). In the earlynegates the inhibitory effects of SOG/CHD on DPP/
embryo, null mutations in dpp cause a complete trans-BMP-type ligands. In transient transfection assays, we
formation of dorsal ectoderm into neurogenic ectoderm,demonstrate that TLD cleaves SOG and that cleavage
while partial loss-of-function mutations can be arrangedis stimulated by DPP. We propose that formation of the
into a phenotypic series in which stronger alleles trans-embryonic DPP activity gradient involves theopposing
form progressively larger regions of dorsal tissue toward
effects of SOG inhibiting DPP and TLD processing SOG
ventral fates (Arora and NuÈ sslein-Volhard, 1992; Fergu-
to release DPP from the inhibitory complex.
son and Anderson, 1992b; Wharton et al., 1993). The
continuum of phenotypes exhibited by dpp alleles first
suggested that cells along the dorsal-ventral axis mayIntroduction
respond differentially depending on the DPP concentra-
tion. Consistent with this view, injection of DPP mRNA
Morphogenetic gradients of diffusible molecules have
into the early embryo can elicit at least two different
long been postulated to control numerous aspects of
cellular responses depending on the concentration (Fer-
development in both vertebrates and invertebrates.
guson and Anderson, 1992a).
Among the first molecularly characterized protein prod-
A DPP concentration gradient also appears to elicit
ucts with morphogenetic activity were the Drosophila differential activation of target genes in the wing disk
homeodomain protein bicoid and the RNA binding pro-
(Lecuit et al., 1996; Nellen et al., 1996). One major differ-
tein nanos (Driever and NuÈ sslein-Volhard, 1988; Irish et ence between the early embryo and the imaginal disks
al., 1989). Key to the production of a morphogenetic
with respect to DPP signaling is the position of the cells
gradient in these cases is a localized source of mRNA responding to DPP. In the wing disk, DPP-producing
and diffusion of the protein product throughout a syncit- cells are found at the anterior/posterior compartment
ium. Once cellularization is achieved, however, simple boundary, while responding cells are located at increas-
diffusion has to becoupled with cell±cell communication ing distances away from the boundary. Therefore, sim-
for graded signals to pass between cells. ple diffusion of the DPP ligand could account for produc-
Recently, members of the TGFb family of growth and tion of a morphogenetic gradient. In the blastoderm,
differentiation factors have been identified as likely se- however, the dorsally located cells that express DPP
creted morphogens (Lecuit et al., 1996; Nellen et al., are the same ones that respond differentially to DPP.
1996). Among the different TGFb subgroups, the BMPs Since dpp transcription appears to be uniform in the
(bone morphogenetic proteins) play particularly promi- dorsal half of the embryo (Ray et al., 1991), a novel
nent roles in early development. These factors were mechanism is required to establish an activity gradient.
originally identified on the basis of their ability to induce It has been proposed that posttranscriptional mecha-
nisms control the formation of the DPP activity gradient
within its expression domain (Arora and NuÈ sslein-Vol-‖ To whom correspondence should be addressed.
hard, 1992; Ferguson and Anderson, 1992b; Wharton et# Present Address: Instituto Cajal, CSIC, Dr. Arce, 37, 28002 Madrid,
Spain. al., 1993; Holley et al., 1996). A key component in the
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production of the embryonic gradient is likely to be the Results
product of the short gastrulation (sog) gene (FrancË ois
TLD Is Secreted and Requires a Proteolyticet al., 1994). SOG is a functional ortholog of Xenopus
Processing Step for ActivationChordin, a factor secreted from the Spemann organizer
All members of the astacin family of metalloproteasesthat counteracts the ventralizing influence of BMP-4 by
that have been examined to date are secreted and re-binding to it and blocking receptor activation (Sasai et
quire removal of an N-terminal propeptide for activityal., 1994; Schmidt et al., 1995; Piccolo et al., 1996). In
(Bond and Beynon, 1995). To determine whether TLD isDrosophila, genetic and in situ hybridization studies
also secreted and requires removal of the N-terminalhave shown that although SOG is produced by ventral-
propeptide for activity, we inserted a triple hemaggluti-lateral cells that abut dpp-expressing cells, SOG acts
nin (HA) epitope at the C-terminal end of the protein,nonautonomously in the dorsal region to inhibit dpp
enabling us to detect TLD by immunochemical methods.signaling (Zusman et al., 1988; FrancË ois et al., 1994).
Several different transformant lines containing a singleThus, diffusion of SOG protein from ventral-lateral cells
copy of the tagged transgene under the control of thecould contribute to the formation of a DPP activity gradi-
tld promoter (Kirov et al., 1994) were able to fully rescueent in the dorsal half of the embryo.
tld null mutants (data not shown), suggesting that the HAIn addition to SOG however, other factors may influ-
epitope did not interfere with TLD function. Subsequentence the shape and/or the rate of gradient formation.
examination of the TLD protein distribution in embryosMutations in the tolloid (tld) gene produce graded phe-
shows that it is localized in dorsal cells in a pattern
notypes similar to dpp lesions (Arora and NuÈ sslein-Vol-
similar to that of the mRNA (compare Figures 1A and
hard, 1992; Ferguson and Anderson, 1992a). When DPP
1B). The uniform distribution of TLD in the dorsal half
levels are enhanced by genetic and physical means, tld
of the embryo suggests that graded translation of TLD
mutant phenotypes can be suppressed, arguing that is not responsible for producing the embryonic DPP
the tld product normally acts to augment DPP activity activitygradient. However, we cannotexclude thepossi-
(Ferguson and Anderson, 1992b). In addition, certain bility that a posttranslational gradient of TLD activity
alleles of tld act antagonistically toward dpp partial loss- might exist in the embryo (see below).
of-function mutations, suggesting that the enhancement The HA-tagged TLD was also used to test whether
could come about by a direct physical association be- TLD is secreted and processed in transiently transfected
tween TLD and DPP or a complex containing DPP Drosophila S2 cells and embryo extracts. As shown in
(Childs and O'Connor, 1994; Finelli et al., 1994). The Figure 1C, size comparison of TLD isolated from S2-
TLD product is a member of a highly related family of conditioned media and cell lysates suggests that TLD
metalloproteases that include BMP-1 (Shimell et al., is processed during secretion. Since the epitope tag is
1991). BMP-1 was initially copurified along with other at the C terminus, this processing most likely represents
BMPs that belong to the TGFb family of growth factors removal of the N-terminal prodomain. The removal of
(Wozney et al., 1988) and has recently been demon- the prodomain is not catalyzed by TLD itself since it is
strated to be the C-terminalprocollagen processing pro- also removed from a putative TLD protease null mutant
tein (Kessler et al., 1996; Li et al., 1996). Several possible (tld10E95, Childs and O'Connor, 1994). To provide further
evidence that the size difference between TLD in themodels for TLD function have been suggested, including
cell pellet versus the supernatant fraction representsthe possibility that TLD may process the DPP ligand
removal of the proregion, we constructed an ªactivatedºitself (Shimell et al., 1991; MarqueÂ s and O'Connor, 1997)
form of TLD in which the propeptide region was removedor a matrix component that might indirectly enhance
by fusing the signal peptide directly to the proteaseDPP activityby promoting its diffusion through theextra-
domain. This activated TLD migrates similarly in bothcellular environment or augmenting its access to recep-
the pellet and supernatant (Figure 1C), and the size cor-tor (Nguyen et al., 1994). A third possibility is that TLD
responds to that of the secreted form of the wild-typecould act on a SOG/DPP complex to cleave SOG and
protein. Conversely, a mutant form that cannot be acti-thereby indirectly regulate DPP activity by releasing it
vated (pmTLD) shows only the high molecular weightfrom this inhibitory complex (Holley et al., 1996; MarqueÂs
form in conditioned medium (Figure 1D).and O'Connor, 1997). In this paper, we present experi-
We next compared the molecular weight of tissue
mental evidence supporting the third possibility. We
culture±expressed TLD to that observed in embryo ex-
show that both TLD and SOG are secreted molecules,
tracts. To our surprise, the majority of the TLD protein
that TLD requires processing for its activity, and, most
in embryos was of the higher molecular weight form
importantly, that expression of TLD leads to the cleav- (Figures 1C and 1E). Since TLD is glycosylated (Figure
age of SOG and this cleavage is greatly stimulated by 1F), it is possible that the embryonic and S2-expressed
the presence of DPP or its vertebrate ortholog BMP-2. forms of TLD might migrate differently in SDS±PAGE as
We also present genetic evidence that SOG function is the result of differential posttranslational modifications.
epistatic to TLD and that TLD is able to counteract the To address this issue more carefully, transformant lines
ability of SOG or CHD to induce secondary axis forma- containing activated TLD under Gal4/UAS control were
tion in Xenopus. These results support a model whereby generated. Extracts from embryos in which UAS-ATLD
the opposing activities of SOG and TLD are responsible is driven by a ubiquitous Gal4 driver (69B) reveal a lower
for establishing the DPP activity gradient in the early molecular weight protein that corresponds in size to the
Drosophila embryo and suggest that similar mecha- activated TLD seen in tissue culture cells (Figure E). We
nisms may influence patterning in vertebrate embryos conclude that most of the TLD in embryos is in the
nonprocessed form.by BMPs.
TLD Processing of SOG
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Figure 1. Biochemical Characterization of the
TLD Protein
(A) Early expression of the TLD protein in the
blastoderm embryo as detected by 12CA5
monoclonal anti-HA antibody. This embryo
was derived from a stock containing eight
copies of a tld promoter±driving TLD-HA con-
struct (pMBO1662).
(B) For comparison, the RNA pattern from a
similarly staged 8 copy embryo is shown.
(C) Western analysis of the TLD-HA protein
and various modified forms. Shown are
transfected S2 cell supernatants (con. med.)
andsoluble cell fraction (Cells) as well as Dro-
sophila embryos. Abbreviations: Cont., mock
transfected cells; TLD, wild-type protein;
ATLD, activated TLD; and TLDo, the TLD10E95
allele. Under embryos, yw is a control non-
transformed fly stock, whereas tld.tld con-
tains two copies of the a wild-type tld-HA
gene being driven by the tld promoter. The
upper arrow indicates the unprocessed form
of TLD while the lower arrow indicates the
processed form (TLD with overbar). For all
blots (C±F), approximately 20 ml of condi-
tioned medium or embryo extract and 5±10
ml of cell pellet were run in the appropriate
lanes. Each blot was probed with anti-HA
12CA5 antibody.
(D) Conditioned medium from S2 cells transfected with either a TLD-HA prodomain processing mutant (pmTLD) or with wild-type TLD-HA
(TLD).
(E) Comparison of TLD-HA from embryos to TLD-HA from tissue culture. TLD, ATLD, and tld.tld are as described in (C), while the 69B lane
shows an extract from 0±8 hr fly embryos containing activated TLD-HA under UAS control being driven by the ubiquitously expressed Gal4
69B driver.
(F) Wild-type TLD-HA (TLD) from conditioned medium is compared to TLD-HA-transfected S2 cells grown in the presence of 100 mg/ml of
tunicamycin (TLD1T). (G and H) The last two panels show the dominant wing phenotype elicited by expression of activated TLD in the wing
disk using the A9 driver (H) compared to a wild-type UAS-TLD construct (G).
The observation that the prodomain is not removed traditional signal sequence. Although both native CHD
and SOG appear to block BMP signaling in Xenopusfrom the majority of TLD found in vivo raises the possibil-
ity that TLD does not need to be processed to have (Holley et al., 1995; Schmidt et al., 1995), for CHD to
have activity in Drosophila, its signal sequence must beactivity. Alternatively, very small amounts of activated
TLD are produced in embryos, perhaps as the result of removed and replaced with the SOG transmembrane
region (Holley et al., 1995). Thus, if SOG is made ina regulated activation step. To examine this possibility,
we ectopically expressed both wild-type and activated ventral-lateral cells of Drosophila and can function by
a nonautonomous mechanism in dorsal cells (Zusmanforms of TLD using the Gal4-UAS system. Using the A9
Gal4 driver, which directs high levels of expression in et al., 1988), then the issue is raised as to whether SOG
is secreted from or remains tethered to the cell surface.the wing pouch, we observed significant differences in
wing morphology when activated TLD is expressed After epitope tagging SOG and verifying that its activity
was unaltered in a Xenopus secondary axis inductioncompared to wild-type TLD (Figures 1G and 1H). Like-
wise, other drivers, such as patched-Gal4 or the ubiqui- assay (see below), we examined the secretion of SOG
in transient transfections of S2 cells. As shown in Figuretous 69B driver, result in dominant pupal and embryonic
lethality, respectively, when expressing activated TLD, 2A, we find that SOG issecreted into themedium without
a concomitant change in size. We also find that SOG,but have no effect on viability or morphology when driv-
ing wild-type TLD (data not shown). These results are like TLD, is glycosylated since the apparent size of the
secreted protein changes when expressed in cellsconsistent with the notion that proteolytic processing
of TLD is required for activity during embryonic develop- grown in the presence of tunicamycin (Figure 2B). These
results suggest that, despite the presence of a trans-ment. We propose that levels of active TLD are con-
trolled by either an inefficient constitutive process or by membrane domain, at least a fraction of the SOG protein
is released from cells, which is consistent with its nonau-an undefined regulated processing mechanism.
tonomous behavior in early embryogenesis.
SOG Is Secreted from Drosophila S2 Cells
Previous sequence analysis of the sog gene revealed
a striking similarity to CHD (Francois and Bier, 1995). sog Is Epistatic to tld
Genetic studies suggest that SOGand TLD act in oppos-However, one unusual difference between the two se-
quences is that SOG contains a Type II transmembrane ing ways to control DPP activity (Ferguson and Ander-
son, 1992a). Using rhomboid (rho) expression as an earlydomain near its N terminus, whereas CHD contains a
Cell
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Figure 2. SOG Is Secreted from S2 Cells
(A) Conditioned media from SOG-Flag/HA-transfected cells (SOG
sup) and an extract from these cells (SOG pellet) were run on SDS±
PAGE and SOG was detected after Western blotting by monoclonal
antibody 12CA5 against HA.
(B) SOG is glycoslyated. Conditioned medium from S2 cells trans-
fected with SOG and grown in the presence (SOG 1 tun) or absence
(SOG) of 100 mg/ml tunicamycin was run on SDS±PAGEs, blotted,
and probed with monoclonal 12CA5 anti-HA antibody.
Figure 3. SOG Is Epistatic to TLD
Cellular blastoderm stage embryos were hybridized with digoxi-
marker for assignment of cell fates along the dorsal- genin-labeled rho and LacZ transcript. Embryos are positioned with
ventral axis (FrancË ois et al., 1994), we investigated the their dorsal sides up and anterior to the left. The appropriate mutant
embryos were identified by the absence of a seven-stripe lacZ pat-epistatic relationship of sog and tld by examining the
tern produced by either the TM3, ftz-lacZ third chromosome bal-phenotype of the double mutant. As shown in Figure 3,
ancer or the FM7, ftz-LacZ first chromosome balancer. (A) 5 wild-tld mutantembryos fail to express rho in the dorsal-most
type, (B) 5 tld2, (C) 5 sog2, and (D) 5 tld2,sog2.
cells, while expression in the ventral-lateral domains is
unaffected. This phenotype is consistent with previous
Schmidt et al., 1995; Zimmerman et al., 1996). By takingstudies showing that in tld mutants the dorsal-most am-
advantage of the secondary axis±inducing ability ofnioserosa cells assume the fates of their dorsal-lateral
these molecules, the effect of TLD on SOG/CHD wasneighbors (Arora and NuÈ sslein-Volhard, 1992). In con-
examined. If TLD can specifically inhibit the function oftrast, sog mutant embryos show an expansion of the
CHD and SOG, by proteolysis for example, we reasonedrho dorsal stripe (Figure 3) also consistent with previous
that coexpression of TLD together with CHD or SOGobservations that sog mutants are partially dorsalized
would block secondary axis induction, but that coex-(FrancË ois et al., 1994). In sog, tld double mutants, the
pression of TLD with Noggin, DN-BMP receptors, orrho expression domain is expanded much as in sog
CmBMPs (cleavage mutant) would not.single mutants (Figure 3). These findings suggests that
Figure 4 (B, D, and F) shows that ventral overexpres-sog function is epistatic to tld, and that TLD is likely to
sion of either DN-BMP receptor, Cm-BMP4, Noggin,exert its phenotypic effect upstream of SOG.
CHD, or SOG induces secondary axes in 80%±100% of
injected embryos. However, when CHD or SOG mRNATLD Is Able to Inhibit SOG/CHD Function
was coinjected together with an equimolar amount ofin a Xenopus Secondary Axis
TLD mRNA, secondary axis induction was blocked, sug-Induction Assay
gesting that TLD is capable of inhibiting SOG or CHDIn Xenopus, ablation of BMP signals in the ventral mar-
function. An intact protease domain is required for inhi-ginal zone by overexpression of dominant-negative (DN)
bition since injection of the TLD10E95 mutant mRNA wasligands or receptors has been shown tounmask underly-
not able to block secondary axis formation (Figure 4D).ing dorsal signaling, thereby inducing dorsal mesoderm
Interestingly, when activated TLD was coinjected withand producing secondary axes (Graff et al., 1994; Suzuki
CHD, secondary axis induction was blocked much moreet al., 1994; Hawley et al., 1995). Overexpression of CHD,
efficiently: i.e., a 10- to 20-fold lower amount of activatedSOG, or Noggin in the ventral marginal zone also leads
TLD mRNA was required to achieve a similar level ofto secondary axis formation as these molecules interact
inhibition to that seen with the full-length transcript (Fig-with and presumably sequester BMPs, thereby pre-
ure 4D). In addition, injection of a processing site mutantventing interaction of the ligands with their cognate re-
ceptors (Holley et al., 1995, 1996; Piccolo et al., 1996; TLD mRNA (pmTLD, Figures 1D and 4D) was unable
TLD Processing of SOG
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Figure 4. Inhibition of SOG/CHD-Mediated Secondary Axis Formation by TLD
(A) Uninjected stage 37 embryos.
(B) Embryos injected with SOG mRNA (2 ng). Secondary axes are present (arrows).
(C) Embryos injected with SOG (2 ng) and TLD mRNA (2 ng). No secondary axis is present.
(D) Histogram showing the induction of secondary axes by Chordin or SOG with various TLD mRNAs. Chordin or SOG mRNA (0.125 mg/ml
and 0.25 mg/ml, respectively) was microinjected into two ventral blastomers (4 nl each) together with wild-type or mutant TLD mRNAs. The
final concentrations of wild-type TLD and activated TLD were 4 ng, 1.5 ng, and 0.4 ng per embryo. For ActTLD10E95 and pmTLD, 4 ng and 1.6
ng of mRNA was injected. Embryos that survived until the late neurula stage were scored. Combined results from three experiments are
shown here. A minimum of 35 (often over 50) embryos were analyzed per injection sample.
(E) Schematic representation of the various forms of TLD products used to make synthetic mRNAs. Abbreviations: TLD, wild-type Tolloid;
ActTLD, activated Tolloid; ActTLD10E95, activated form of protease mutant; pmTLD, processing mutant; pp, propeptide; Zn, zinc protease
domain; CUB, CUB repeat; E, EGF-repeat; H, HA epitope.
(F) Expression of activated TLD (0.4 ng, 1.5 ng, and 4.0 ng per embryo) does not block secondary axis formation mediated by noggin (100
pg), DN-BMPR (2 ng), and Cm-BMP4 (2 ng) mRNA injected.
to block secondary axis induction. The findings that a and TLD. S2 cells were transfected with DPP-HA, SOG-
Flag/HA, and TLD-myc alone and in various combina-processed form of TLD is more active than the unpro-
cessed form and that a processing site mutant is inactive tions. As shown in Figure 5A, SOG is cleaved in at least
three positions, when both TLD and DPP are present.are consistent with the notion that the activation of TLD
in Xenopus is regulated by an as yet unidentified prote- In the absence of DPP, very little cleavage is seen. How-
ever, overexposure of the blot does reveal a small de-ase. To test the specificity of the activated form of TLD
on SOG and CHD, we coinjected activated TLD mRNA gree of processing at approximately the same positions.
We do not know whether this represents intrinsic TLDtogether with other molecules capable of inducing sec-
ondary axes. As shown in Figure 4F, activated TLD was activity in the absence of ligand or perhaps that S2 cells
express a low level of some ill-defined BMP-type ligand.unable to inhibit secondary axis induction mediated by
To demonstrate that SOG cleavage is dependent onNoggin, DN-BMP receptor, or CmBMPs. Together with
TLD activity, transfections in which the wild-type TLDthe epistatic analysis, these results strongly suggest
was replaced with the TLD10E95 protease domain mutantthat TLD acts specifically to block the antagonistic inter-
(Figure 5A) or the TLD proregion processing site mutantaction of SOG/CHD with BMP-type ligands.
were carried out (data not shown). In neither case is
SOG cleaved, thus demonstrating that the processing
of SOG is dependent upon TLD activity. A similar patternThe TLD Protein Is Able to Cleave SOG
in the Presence of DPP or BMPs of processing is also seen upon mixing of supernatants
isolated from individually transfected cells, grown eitherThe simplest model for TLD function that explains both
the genetic epistasis results and the inhibition of SOG/ with or without serum, indicating that a cell surface envi-
ronment is not necessary for cleavage (Figure 5B). AsCHD activity in secondary axis induction is that SOG is
a substrate for proteolysis by TLD. We directly tested found in cotransfections, DPP or BMP-2 is required for
processing of SOG by TLD. We also find that cleavagethis model using conditioned media from Drosophila S2
cells expressing epitope-tagged forms of DPP, SOG, is specifically stimulated by BMP-type ligands but not
Cell
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Figure 5. Coexpression of TLD and DPP with SOG Leads to SOG Cleavage
(A) Conditioned media from cells transfected with the indicated constructs were subjected to SDS±PAGE and Western blot analysis. The SOG
protein and cleavage products were detected by anti-Flag polyclonal antibody D-8. Expression of DPP and TLD was confirmed on separate
blots by Western analysis (data not shown). Note that coexpression of SOG with DPP and either TLD or activated TLD, but not protease-
dead forms of these proteins (TLDo and ATLDo) leads to cleavage of SOG in at least three places, producing fragments of 100, 45, and 25
kDa. We occasionally see a fourth 16 kDa band as seen in the sample containing activated TLD (lane 5), but the presence of this fragment
is quite variable and is not always seen. It might represent secondary degradation of the 25 kDa fragment by an unidentified protease.
(B) Mixing of conditioned media from individually transfected cells also leads to SOG cleavage. Conditioned medium (20 ml) from SOG-Flag
transfected cells grown either with serum (first panel) or without serum (second panel) was mixed with 10 ml of conditioned media from TLD-
HA-transfected cells and incubated for 24 hr. before SDS±PAGE and Western blotting. Note that very little cleavage of SOG is detected in
the absence of ligand. When conditioned medium (5 ml) from DPP-expressing cells (lane 2, first panel) or 10 ng of purified BMP-2 was also
included during the 24 hr incubation, the same fragmentation pattern that was seen as a result of cotransfection as shown in (A) is seen. In
the bottom portion of (B), the approximate locations of the cleavage sites in SOG are illustrated relative to the four procollagen-like domains
(CR) and thrombospondin domains (SR).
(C) Cleavage of SOG is stimulated by BMP-2 and 4 but not activin or TGFb1. SOG-Flag/HA-containing conditioned medium (20 ml) was
incubated as indicated on top of each lane with either 0 or 5 ml of TLD-myc-containing conditioned medium together with 10 ng of purified
BMP-2, BMP-4, activin A, or TGFb1 for 8 hr at 218C. SOG fragmentation was detected by the monoclonal 12CA5 anti-HA antibody.
by activin or TGFb (Figure 5C). Taking these results blocks DPP activity (Biehs et al., 1996; Holley et al.,
1996). While this simple diffusion mechanism could gen-together, we propose that DPP-dependent cleavage of
SOG by TLD is stimulated by conformational changes erate a DPP activitygradient given the appropriate phys-
ical properties of SOG, i.e., concentration, diffusion co-induced in SOG by binding to ligand.
efficient, turnover rates, and affinity for DPP, we suggest
that these properties alone are not sufficient to produceDiscussion
a proper gradient and that the TLD protein is crucial for
determining the correct shape and/or rate of gradientThe Opposing Activities of SOG and TLD Are
Likely to Produce the Embryonic formation.
A role for TLD in dorsal-ventral patterning was firstDPP Activity Gradient
The graded phenotypes produced by partial loss-of- suggested on thebasis of the tld mutant phenotype. TLD
mutant embryos show a partially ventralized phenotypefunction mutations in several zygotically acting genes
first suggested that a molecule with morphogenetic similar to weak dpp alleles. Furthermore, hypomorphic
alleles of tld can be suppressed by addition of extraproperties was required to pattern dorsal tissues in the
early Drosophila embryo (Arora and NuÈ sslein-Volhard, copies of dpp, indicating that tld acts to enhance dpp
activity (Ferguson and Anderson, 1992b). The existence1992; Ferguson and Anderson, 1992b; Wharton et al.,
1993). Several studies have shown that the molecule of several antimorphic tld alleles that act antagonisti-
cally toward partial loss-of-function dpp alleles has leadthat best fits the criteria for a morphogen is DPP; how-
ever, the specific molecular mechanism involved in gen- to the suggestion that TLD augments DPP activity by
interacting either with DPP or with a complex containingerating the DPP activity gradient in the dorsal half of
the embryo has remained elusive. We have provided DPP (Childs and O'Connor, 1994; Finelli et al., 1994).
Most antimorphic alleles map to the TLD protease do-evidence in this paper that the opposing activities of
the SOG and TLD products play major roles in modulat- main, consistent with the idea that they are able to bind
to a complex containing DPP but do not process oneing DPP activity. One attractive model for SOG function
suggested by its genetic and biochemical properties is of the components properly (Childs and O'Connor, 1994;
Finelli et al., 1994). The observations described in thisthat SOG protein diffuses from ventral-lateral cells into
the dorsal region of the Drosophila embryo where it paper not only are compatible with these previously
TLD Processing of SOG
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described genetic interactions, but also allow us to for- the production of excess amnioserosa. However, fully
differentiated amnioserosa, as defined by staining formulate a more detailed molecular model that explains
the complex genetic behavior of tld mutants. We have the KruÈ ppel or Hindsight gene products, is never realized
in sog mutants (M. M. and M. B. O'C., unpublished data),shown here that TLD activity leads to cleavage of SOG
in the presence of DPP. We propose that this processing even though an early marker for the dorsal-most tissue,
rho, is expanded(FrancË ois et al., 1994, and in this report).is direct. We note, however, that we cannot exclude the
possibility that TLD initiates a proteolytic cascade that One explanation is that SOG binding to DPP in ventral-
lateral regions could assist in forming a peak of DPPeventually leads to cleavage of SOG. Nevertheless, the
end result is that SOG/DPP complexes are cleaved, and activity if DPP was carried some distance dorsally by
SOG diffusion before being released by TLD action (Hol-we propose that this processing releases active ligand
(see Piccolo et al., 1997 [this issue of Cell]). This model ley et al., 1996). In this model, the early rho expansion
is caused by higher than normal levels of DPP in dorsal-is also consistent with our finding that injection of TLD
into Xenopus embryos inhibits the ability of coinjected lateral regions. However, since this DPP would never
be focused to the dorsal-most region, final formationSOG or CHD to induce a secondary axis. We propose
that in tld mutant embryos, excess SOG diffuses into of amnioserosa could be blocked if a later stage of
differentiation requires an even higher level of dpp sig-the dorsal region and causes the partially ventralized
phenotype as a result of enhanced inhibition of DPP. In naling than is achieved only by the SOG-focusing effect
on DPP. While this mechanism is possible, we suggestthis view, TLD acts to control the shape and/or produc-
tion rate of the DPP gradient by controlling the amount that an alternative explanation could account for the
lack of amnioserosa differentiation. In this alternativeof functional SOG present in the dorsal region.
model, a second signal, that is not produced in SOG
mutants, is required for terminal differentiation of amnio-Levels of Active TLD May Help Control
serosa cells. An attractive possibility is that one of thethe Slope of the DPP Gradient
SOG cleavage products could be such a signal. AnotherFor the DPP gradient to form properly, i.e., low DPP in
potential candidate for a second signal is the twisteddorsal lateral regions and high DPP at the dorsal midline,
gastrulation (tsg) gene product or a complex of TSG andeither some component of thesystem must be immobile,
one of the SOG cleavage products. TSG is a secretedor the amount of SOG protein must be in great excess
molecule with weak similarity to connective tissuerelative to DPP and active TLD. Otherwise, TLD and DPP
growth factor and, unlike other zygotic mutants of thediffusing from the dorsal region might be expected to
D/V patterning system that produce partially ventralizedeliminate SOG protein altogether before it diffused to
phenotypes (scw, tld, and shrew), tsg mutants only ef-the dorsal side. This effect would be further enhanced
fect formation of the amnioserosa (Mason et al., 1994).by the presence of SCW (screw) in the ventral domain
Whether functional TSG is produced in sog mutants has(Arora et al., 1994), since we find that like DPP, SCW is
not yet been examined.able to stimulate TLD cleavage of SOG (M. Nguyen,
G. M., and K. Arora, unpublished data). Additionally, the
recent observation that DPP is able to activate its own Do TLD-Like Proteins Control BMP
transcription in ventral-lateral regions in the absence of Activity in Vertebrates?
SOG (Biehs et al., 1996) would be expected to further Several studies have now indicated a striking conserva-
augment clearing of SOG. This apparent paradox may tion of molecules that are involved in patterning the
have been resolved during evolution by limiting the pro- dorsal-ventral axis of vertebrates and invertebrates, in-
duction of mature TLD. The low level of TLD activation, cluding BMP-type ligands and Chordin/SOG inhibitors
perhaps coupled with poor diffusion, could prevent a (Francois and Bier, 1995; Holley et al., 1995; Schmidt et
sufficient quantity of processed TLD from building up al., 1995). While the polarity of the axis appears to have
to a point where it could effectively eliminate SOG mole- inverted during evolution, it is likely that the biochemical
cules in ventral cells before they have a chance to diffuse mechanisms acting in both cases are retained. The re-
dorsally. Thus, TLD activation may be crucial to ensuring cent identification of mutations in the zebrafish Chordin
a correct slope to the DPP gradient. Whether TLD pro- homolog strengthen this view by providing phenotypic
cessing is actively regulated or simplyan inefficient con- evidence supporting the role of Chordin in vertebrate
stitutive process is unclear. axis formation (Schulte-Merker et al., 1997). This raises
the issue of whether a TLD homolog is involved in the
production of a BMP gradient in vertebrates as well.The sog Mutant Phenotype Paradox
Although the simple inhibition and cleavage model pre- Although severaldifferent TLD-like molecules have been
described in a number of organisms (reviewed in Bondsented above can account for most aspects of the sog
and tld mutant phenotypes, there is one puzzling aspect and Beynon, 1995; Sarras, 1996), they vary in thenumber
and arrangement of CUB and EGF-like domains, sug-of the sog phenotype that is difficult to reconcile with
such a model. As pointed out by Holley et al. (1996), the gesting that they may have different primary functions
(Nguyen et al., 1994). In mammals, the initial member ofamnioserosa is derived from the dorsal-most blasto-
derm cells and is thought to require the highest levels the TLD family was BMP-1, a protein that copurifed with
several of the TGFb-type BMP ligands (Wozney et al.,of dpp activity for its formation. By the simple inhibition
model, one would expect that in sog mutant embryos, 1988). More recently, the BMP-1 locus has been shown
to produce several alternatively spliced products includ-abnormally high levels of DPP would be present
throughout the dorsal half of the embryo, leading to ing BMP-1, mTLD, and mTLD-his (Takahara et al., 1994).
Cell
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The mTLD protein shares a domain structure similar to be useful to an organism during different stages of de-
Drosophila TLD. Despite the initial connection to BMP velopment.
signaling that was implied by copurification of BMP-1
with BMP ligands, BMP-1 has recently been shown to Experimental Procedures
remove the C-terminal globular domains from types I±III
Plasmid Construction and Epitope Taggingprocollagen (Kessler et al., 1996; Li et al., 1996). Barring
Detailed methods for the construction of all plasmids used in thisredundancy, these observations, together with the fact
work are available upon request. Briefly, a triple copy of the HA
that the mouse knockout phenotype (Suzuki et al., 1996) epitope (YPYDVPDYA) was placed in TLD by conventional cloning
does not show defects in early axial development, impli- methods after a NotI restriction enzyme site was introduced at the
cate thevarious products of the BMP-1 locus inextracel- C-terminal end of TLD by site-directed mutagenesis. The NotI site
lular matrix processing rather than in BMP signaling. is located just after Ser-1054. The same restriction enzyme site was
used to tag TLD with the 63 myc epitope (MEQKLISEEDLNE) ofAnother possible vertebrate candidate for a true func-
pCS31MT. The tld10E95 antimorphic mutant was made by site-tional homolog of TLD is the recently described tolloid-
directed mutagenesis. Activated TLD was also made by site-like product mtll (Takahara et al., 1996). This protein also
directed mutagenesis. A 300 bp loop-out that removes nucleotideshas the same domain structure as TLD and mTLD but
178±477 results in the fusion of Gly-26 to Ala-127. For the TLD
is expressed in additional tissues where mTLD is not processing site mutant (pmTLD), PCR mutagenesis was used to
found. As described in the accompanying article (Pic- change Arg Arg Arg Arg (AA 123±126) to Leu Ile Asn Leu. SOG was
colo et al., 1997), a Xenopus homolog of mtll, Xolloid, tagged with the Flag epitope (DYKDDDDK) using PCR. The Flag
epitope falls after Arg-1122. Subsequent to tagging with Flag, SOGwas discovered based on its ability to induce partial
was also tagged with 33 HA at a restriction enzyme site that wasposteriorization and ventralization when injected into
positioned just prior to Flag, creating SOG-Flag/HA. DPP with adorsal regions of the Xenopus embryo. Furthermore,
single myc tag after Asp-485 was obtained from Russell Nicholls
XLD is able to cleave CHD and release active BMP-4 and Bill Gelbart. A HindIII site between K and L of the myc epitope
from an inhibitory complex, making it likely that it func- was used to introduce 33 HA. All sequence junctions were con-
tions in a manner analogous to Drosophila TLD to help firmed by DNA sequencing.
establish a gradient of BMP activity in vertebrates. The tagged proteins described above were placed in different
vectors for various purposes. Bluescript II KS1 (Stratagene) wasWhile XLD exhibits a number of functional similarities
used for Xenopus injections. pRmHaI (Bunch et al., 1988) was usedto TLD, it also displays several differences. The most
for transfections into S2 cells. pCasPeR4 (Pirotta, 1986) and pUASTnotable are a lack of ligand stimulation of CHD cleavage
(Brand and Perrimon, 1993) were used for making P element±
and fewer cleavage sites in CHD. There are several pos- mediated germline transformants.
sible explanations for these biochemical differences.
First, the total number of cleavage sites may not be as Drosophila Strains, Germline Transformations,
important to biological function as is the position of at and In Situ Hybridization
least one of the sites. For CHD, cleavage after the most The sogYl21 allele was obtained from Eric Wiesshaus and is a moder-
ate allele (Ferguson and Anderson, 1992b). The tldB4 allele convertsN-terminal site appears to be sufficient for elimination
Gln-44 to a TAG stop codon (Childs and O'Connor, 1994) and isof BMP inhibiting activity (see Piccolo et al., 1997), and
assumed to be a null allele. The balancers FM7, ftz-lacZ and TM3,this site appears to be conserved in SOG. Alternatively,
ftz-lac Z wereobtained from the Bloomington stock center. Germlinethe binding properties of SOG to DPP may be different
transformation using the pCasPeR (Pirotta, 1986) and pUAST vec-
than those of CHD to BMP-4. Since CHD and SOG are tors (Brand and Perrimon, 1993) has been previously described
only 27% identical, perhaps additional cleavages are (Nguyen et al., 1994). In situhybridization and immunocytochemistry
required in Drosophila to completely release DPP from was performed according to previously published methods (Nguyen
et al., 1994).SOG.
The second major difference between our two findings
Xenopus Embryo Manipulations and Microinjectionis that Xolloid does not show a pronounced dependence
Xenopus embryos were obtained by in vitro fertilization of eggs withupon ligand for cleavage of CHD. This may simply indi-
testes homogenates. Embryos were dejellied in 2% cysteine andcate that the appropriate ligand has not yet been tested.
staged according to Nieuwkoop and Faber (1994). For secondary
We have found that TLD will cleave SOG in the presence axis induction assays, synthetic mRNAs were injected into the equa-
of both SCW and 60A (our unpublished data); however, torial region of two adjacent ventral blastomeres of four-cell stage
we do not know if the rates of cleavage are the same embryos after sorting according to their pigmentation patterns. The
injection volume was 4 nl into each blastomere at the concentrationsin these casesas for DPP. Anothermore intriguing possi-
indicated. mRNAs for microinjection were transcribed using eitherbility is that the properties of individual TLD-like mole-
the T3, T7, or Sp6 Message Machine kits (Ambion).cules are exploited somewhat differently in each case.
The ligand dependence of Drosophila SOG cleavage
Transfection Methodscould help generate a long-range gradient of DPP activ-
Drosophila S2 cells were grown in M3 insect medium (Sigma) con-
ity by enabling the free SOG concentration to rise at a taining 100 units/ml penicillin G and 100 mg/ml streptomycin with
faster rate in tissue far from its source than if the free or without (serum-free) 10% fetal calf serum. Transfections were
SOG was also rapidly targeted for degradation by TLD carried out exactly as described by Cherbas et al. (1994). After 12±16
action. In contrast, Xolloid, by virtue of its ability to hr incubation, the medium was removed and the cells were washed
twice with 10 ml of PBS. Production of the relevant proteins wascleave free CHD, may serve a very different function,
induced by addition of 4 ml of M3 medium containing 500 mMwhich is to eliminate any free CHD that diffuses too far
CuSO4. After 48 hr, the cells were harvested and removed fromfrom its site of synthesis. In this way, XLD might actually
the conditioned media by low-speed centrifugation. The cleared
help confine the inhibitory effects of CHD to very local supernatant (conditioned medium) was used directly for cleavage
environments. It is easy to envision how both types of assays and Western blotting. The soluble cell pellet fraction was
mechanisms, one that helps promote long-range inhibi- obtained by lysing cells in PBS containing 0.5% Triton X-100 and
1 mM EDTA. The cell debris was pelleted by centrifugation (15,000 3tory effects and one that helps limit these effects, could
TLD Processing of SOG
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g) for 10 min, and the clarified supernatant is defined as the soluble and repression of the activity of the TGF-b family member, decapen-
taplegic, is necessary for dorsal-ventral pattern formation in thecell pellet fraction. For inhibition of glycosylation, cells were grown
in the presence of 100 mg/ml tunicamycin. Drosophila embryo. Development 114, 583±597.
Finelli, A.L., Bossie, C.A., Xie, T., and Padgett, R.W. (1994). Muta-
Western Blot Analysis tional analysis of the Drosophila tolloid gene, a human BMP-1 homo-
For Western blot analysis, proteins from conditioned medium, solu- log. Development 120, 861±870.
ble cell fraction, or embryo extracts were separated by SDS±PAGE Francois, V., and Bier, E. (1995). Xenopus chordin and Drosophila
on either 7% or 7%±15% gradient gels and electroblotted onto short gastrulation genes encode homologous proteins functioning
PVDF membranes (Millipore). Primary antibodies were used at the in dorsal-ventral axis formation. Cell 80, 19±20.
following dilutions: 12CA5 monoclonal anti-HA (Boehringer Mann-
FrancË ois, V., Solloway, M., O'Neill, J.W., Emery, J., and Bier, E.heim) 1 mg/ml, 9E10 anti-myc tissue culture supernatant (gift from
(1994). Dorsal-ventral patterning of the Drosophila embryo dependsMark Peifer), anti-Flag rabbit polyclonal D-8 (Santa Cruz BioMedical)
on a putative negative growth factor encoded by the short gastrula-0.1 mg/ml. Immune complexes were visualized using horseradish
tion gene. Genes Dev. 8, 2602±2616.peroxidase±conjugated secondary antibody (BioRad or Promega at
Gelbart, W.M. (1989). The decapentaplegic gene: a TGF-b homolog1:5000 dilution) and the ECL system (Amersham) using exposure
controlling pattern formation in Drosophila. Development 107times of 10 sec to 50 min.
(Suppl.), 65±74.
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